However, potential side effects, especially gastrointestinal issues, may be more pronounced when these drugs are used in combination
Toripalimab in combination with HBM4003, an anti-CTLA-4 heavy chain-only antibody, in advanced melanoma and other solid tumors: an open-label phase I trial
Diabetes and obesity: therapeutic targeting and risk reductiona complex interplay
This generalised itching may occur in the absence of obvious skin changes and can be distressing for affected individuals
Results in trial reports (primary trial results and subsequent secondary publications), and their accompanying Additional file 1, were used as the primary source of information
Vitamin C Vitamin C and glutathione have a beautiful partnership